Brought to you by 
ProdiGene, LSBC in antibody deal
14 Mar 2001
Executive Summary
Large Scale Biology Corp. (identifies and characterizes proteins) will use its facility to manufacture therapeutic antibodies utilizing ProdiGene Inc.'s (develops recombinant proteins from transgenic plants) technologies and expertise in protein production.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Transgenics
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ProdiGene, LSBC in antibody deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice